Clinical trial
Trial of BMS-986012 in Combination With Platinum and Etoposide
NCT02815592
Study timeline
Study start (actual)2016-11-28Date precision: day
Registry last updated2024-09-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancerunresolved
Interventions
BMS-986012DRUG
CisplatinDRUG · verified · RxNorm: cisplatin
EtoposideDRUG · verified · RxNorm: etoposide
PlatinumDRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02815592 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.